ACTRN12610000938000招募中2 期
'A Phase II randomised controlled trial of follow up of men with prostate cancer in primary care, to assess the acceptability and feasiblity of a shared care model'
Primary Care Collaborative Cancer Clinical Trials Group0 个研究点目标入组 188 人开始时间: 2010年11月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 188
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Male
入选标准
- •1. Pathologically confirmed diagnosis of prostate cancer.
- •2. Completed surgery and / or radiotherapy with curative intention within 3 weeks of study entry
- •3. Able to read and write English at a level sufficient to give informed consent and complete study procedures including written questionnaires without an interpreter.
- •4. Have a general practitioner who agrees to participate in the Trial.
排除标准
- •1. Suspicion or evidence of metatastic disease
- •2. Severe psychiatric or cognitive disorder, which in the opinion of the investigator would compromise participation in the study.
- •3. Treatment with palliative intent.
- •4. No general practitioner.
- •5. Patients with a pathologically confirmed diagnosis of prostate cancer with any of the following high risk features (cT3; PSA greater than 20; or Gleason score greater than or equal to 8)
- •6. Patients having androgen deprivation therapy following radiotherapy, irrespective or risk level
研究者
相似试验
尚未招募
不适用
A short-term ketogenic diet combined with 24-hour fasting and chemoprotection for patients with acute myeloid leukaemiaacute myeloid leukemiaACTRN12620000850976epean Blue Mountains Local Health District134
已完成
不适用
Enhancing decision-making about treatment in bipolar II disorder: Evaluation of a treatment decision-aid for patients and their family.Bipolar II disorderMental Health - Other mental health disordersACTRN12617000840381A/Prof Ilona Juraskova196
已完成
2 期
Continued use of Atorvostatin in sepsisSepsis / infection in patients taking statin therapyBlood - Studies of infection and infectious agentsACTRN12605000756628Dr Peter Kruger, Intensive Care Specialist, Princess Alexandra Hospital, Brisbane200
已完成
2 期
A phase IIb randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients BLING IISevere Sepsis in the Intensive Care patientInfection - Studies of infection and infectious agentsBlood - Other blood disordersACTRN12612000138886HMRC442
进行中（未招募）
1 期
eoadjuvant Nivolumab and chemotherapy in stage I-II triple negative breast cancer.Early stage triple negative breast cancerEUCTR2019-003465-18-ITBreast Cancer Trials108